Pharmaron Beijing (H Dividend yield




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   HKD per share 
 Price  103.00
 Dividend  0.16
 Earnings  4.66
 Cash-flow  7.30
 Book value  64.38
 Equity  42.75

Pharmaron Beijing (H is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Pharmaron Beijing (H is a company from China, and his stocks are publicly traded.

Pharmaron Beijing (H paid a total dividend of 21 million HKD last year, for a market value of 13,802 millions (Market Cap 8,735 millions). Dividend per share of Pharmaron Beijing (H is 0.16 HKD, and his stock market price 103.00 HKD.

According to the chart below, where dividend yield is displayed, Pharmaron Beijing (H has a dividend yield of 0.16%, lower than the amount offered by both the market average and companies from China. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Pharmaron Beijing (H dividend yield with other Pharmaceuticals and Biotechnology companies or firms from China.

Dividend yield of Pharmaron Beijing (H

Pharmaron Beijing (H Dividend Payout

About the ability of Pharmaron Beijing (H to maintain his current dividend of HKD 0.16 per share, an amount that accounts for 0.16%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Pharmaron Beijing (H payout on ernings is currently 3.43%, which is lower than the market average and companies of Health Care industry, which are 37.66% and 28.10% respectively. Both figures lead us to believe that there is confidence that Pharmaron Beijing (Hcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Pharmaron Beijing (H is HKD 7.30 per share, which is higher than the dividend per share paid by the company of HKD 0.16, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Pharmaron Beijing (H, compared againt world market average, China companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Pharmaron Beijing (H payout

Pharmaron Beijing (H Stock performance

Finally, last moth Pharmaron Beijing (H showed a return of 22.40% compared to a worldwide 4.36% average, and a 1.76% of Health Care firms. Over the last year, the company obtained a 0.00% versus a worldwide performance of a 2.14%. More detailed information can be seen in the following graph for China and Pharmaceuticals and Biotechnology firms.

Pharmaron Beijing (H stock and market return

Next companies

Philip Morris CR AS. Czeck Republic. Consumer Goods.

Philip Morris Intern. USA. Consumer Goods.

Philips Lighting NV. Netherlands. Industrials.

Phillips 66. USA. Oil and Gas.

Phoenix Group Holding. UK. Financials.

Phoenix Holdings. Israel. Financials.

Previous companies

PG & E Corp.. USA. Utilities.

Pfizer. USA. Health Care.

Peugeot. France. Consumer Goods.

Petronet LNG. India. Utilities.

Petronas Gas. Malaysia. Oil and Gas.

Petronas Dagangan Bh. Malaysia. Oil and Gas.

 

 

All rights reserved

 information advertisement legal

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.